MENS

Healthcare Biotechnology

Jyong Biotech Ltd.

$2.05

-0.15 -6.62% today

Price History

Not enough data

Key Stats

Market Cap

155.86M

Avg Volume

47,643

EPS

-$0.06

52W High

$63.00

52W Low

$1.43

Div. Yield

0.0%

Valuation

P/B Ratio

-6.10

EV/EBITDA

-67.63

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(12.0%)

Liquidity & Leverage

Current Ratio

0.45

Quick Ratio

0.03

Total Cash

1.18M

Total Debt

18.55M

About

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.

jyongbio.com